Cipla Lines Up Advair But Costs Will Flatten High-Value Launches

Higher R&D Costs And Market-Driven Inflation Expected In 2022/23

Sergei Babenko/Alamy Stock Photo
How profitable will the planned Advair Gx be? • Source: Shutterstock (Sergei Babenko / Alamy Stock Pho/Alamy Stock Photo)

More from Earnings

More from Business